TWI468405B - １Ｈ－吡唑并〔４，３－ｃ〕異喹啉衍生物、其製備及其於醫療上之應用 - Google Patents
１Ｈ－吡唑并〔４，３－ｃ〕異喹啉衍生物、其製備及其於醫療上之應用 Download PDFInfo
- Publication number
- TWI468405B TWI468405B TW99112914A TW99112914A TWI468405B TW I468405 B TWI468405 B TW I468405B TW 99112914 A TW99112914 A TW 99112914A TW 99112914 A TW99112914 A TW 99112914A TW I468405 B TWI468405 B TW I468405B
- Authority
- TW
- Taiwan
- Prior art keywords
- difluorophenyl
- pyrazolo
- group
- amino
- hexahydropyridin
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 10
- YMYHYKRSWYKSJM-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline Chemical class N1=CC2=CC=CC=C2C2=C1C=NN2 YMYHYKRSWYKSJM-UHFFFAOYSA-N 0.000 title description 3
- 239000003814 drug Substances 0.000 title description 2
- -1 2,6-difluorophenyl Chemical group 0.000 claims description 74
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 63
- 150000001875 compounds Chemical class 0.000 claims description 61
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 55
- 125000006239 protecting group Chemical group 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 25
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 23
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 19
- 125000004551 isoquinolin-3-yl group Chemical group C1=NC(=CC2=CC=CC=C12)* 0.000 claims description 15
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 12
- 229940124530 sulfonamide Drugs 0.000 claims description 12
- 125000000524 functional group Chemical group 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- JGMSGABJHLXRRW-UHFFFAOYSA-N isoquinoline-7-carbonitrile Chemical compound C1=CN=CC2=CC(C#N)=CC=C21 JGMSGABJHLXRRW-UHFFFAOYSA-N 0.000 claims description 7
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 7
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 229910052731 fluorine Chemical group 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- WCUDWYLAQUZKTO-UHFFFAOYSA-N 1-azido-10,10-dimethylundecane Chemical compound CC(C)(C)CCCCCCCCCN=[N+]=[N-] WCUDWYLAQUZKTO-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- STCPUAMYUVSVEY-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=CC=C22)=C1N=C2C1=C(F)C=CC=C1F STCPUAMYUVSVEY-UHFFFAOYSA-N 0.000 claims description 4
- RGGLAPZYXTXDGZ-UHFFFAOYSA-N isoquinoline-7-carboxamide Chemical compound C1=CN=CC2=CC(C(=O)N)=CC=C21 RGGLAPZYXTXDGZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- IJBGDEFHSQBFSG-UHFFFAOYSA-N 3-[(1-cyclopropylsulfonylpiperidin-4-yl)amino]-5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2NC1CCN(S(=O)(=O)C2CC2)CC1 IJBGDEFHSQBFSG-UHFFFAOYSA-N 0.000 claims description 3
- KAMIUDBIEZUGRD-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F KAMIUDBIEZUGRD-UHFFFAOYSA-N 0.000 claims description 3
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 239000007806 chemical reaction intermediate Substances 0.000 claims description 3
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 2
- NQJCBCPYVOOEHU-UHFFFAOYSA-N 3-[(1-cyclopropylsulfonylpiperidin-4-yl)amino]-5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)N)=CC=C3C=2NN=C1NC(CC1)CCN1S(=O)(=O)C1CC1 NQJCBCPYVOOEHU-UHFFFAOYSA-N 0.000 claims description 2
- MEKAPJIREIGICY-UHFFFAOYSA-N 4-[[5-(2,6-difluorophenyl)-7-fluoro-1h-pyrazolo[4,3-c]isoquinolin-3-yl]amino]piperidine-1-sulfonamide Chemical compound C1CN(S(=O)(=O)N)CCC1NC1=NNC(C2=CC=C(F)C=C22)=C1N=C2C1=C(F)C=CC=C1F MEKAPJIREIGICY-UHFFFAOYSA-N 0.000 claims description 2
- HDPQMXVWWMHIPF-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=C22)C(N)=O)=C1N=C2C1=C(F)C=CC=C1F HDPQMXVWWMHIPF-UHFFFAOYSA-N 0.000 claims description 2
- HVIJNAFSDFOABE-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=O)C=C22)=C1N=C2C1=C(F)C=CC=C1F HVIJNAFSDFOABE-UHFFFAOYSA-N 0.000 claims description 2
- DSJVZAMEIDDNFJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[[1-(trifluoromethylsulfonyl)piperidin-4-yl]amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)N)=CC=C3C=2NN=C1NC1CCN(S(=O)(=O)C(F)(F)F)CC1 DSJVZAMEIDDNFJ-UHFFFAOYSA-N 0.000 claims description 2
- POXMAXYPOXUVSC-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethynyl-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C#C)=C1N=C2C1=C(F)C=CC=C1F POXMAXYPOXUVSC-UHFFFAOYSA-N 0.000 claims description 2
- CFVDITVGKOGSEN-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-fluoro-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(F)C=C22)=C1N=C2C1=C(F)C=CC=C1F CFVDITVGKOGSEN-UHFFFAOYSA-N 0.000 claims description 2
- ANAJNNLDOVJWNJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-N'-hydroxy-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinoline-7-carboximidamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C(=N)NO)=C1N=C2C1=C(F)C=CC=C1F ANAJNNLDOVJWNJ-UHFFFAOYSA-N 0.000 claims description 2
- QPDRVSSQFCIGML-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-7-(1h-pyrazol-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C3=CNN=C3)=C1N=C2C1=C(F)C=CC=C1F QPDRVSSQFCIGML-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000006352 cycloaddition reaction Methods 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- PVHJRQFBILZDHB-UHFFFAOYSA-N 2h-pyridine-1-sulfonamide Chemical compound NS(=O)(=O)N1CC=CC=C1 PVHJRQFBILZDHB-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- OUQVKRKGTAUJQA-UHFFFAOYSA-N n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine Chemical compound C1=CC=CC2=C(O)C(C(=O)NCC(=O)O)=NC(Cl)=C21 OUQVKRKGTAUJQA-UHFFFAOYSA-N 0.000 claims 1
- WINWAFCAQPFBQA-UHFFFAOYSA-N quinoline-7-carbaldehyde Chemical compound C1=CC=NC2=CC(C=O)=CC=C21 WINWAFCAQPFBQA-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 327
- 239000000203 mixture Substances 0.000 description 235
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 171
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 163
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 154
- 239000007787 solid Substances 0.000 description 126
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 81
- 229910052786 argon Inorganic materials 0.000 description 77
- 239000000243 solution Substances 0.000 description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 71
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 70
- 239000000741 silica gel Substances 0.000 description 70
- 229910002027 silica gel Inorganic materials 0.000 description 70
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 68
- 238000005481 NMR spectroscopy Methods 0.000 description 67
- 239000000047 product Substances 0.000 description 64
- 238000003818 flash chromatography Methods 0.000 description 58
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 51
- 238000001816 cooling Methods 0.000 description 49
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 38
- 238000000105 evaporative light scattering detection Methods 0.000 description 35
- 239000012074 organic phase Substances 0.000 description 29
- 238000010992 reflux Methods 0.000 description 28
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 22
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 22
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 21
- 235000011114 ammonium hydroxide Nutrition 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 20
- 229920006395 saturated elastomer Polymers 0.000 description 20
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 235000019439 ethyl acetate Nutrition 0.000 description 18
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000008346 aqueous phase Substances 0.000 description 16
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 16
- 229910000024 caesium carbonate Inorganic materials 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 16
- 238000000746 purification Methods 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000006071 cream Substances 0.000 description 15
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 15
- 230000005587 bubbling Effects 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 11
- 238000004587 chromatography analysis Methods 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 10
- FLQSRSQNICPZIH-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-amine Chemical compound CS(=O)(=O)N1CCC(N)CC1 FLQSRSQNICPZIH-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 229910052794 bromium Inorganic materials 0.000 description 9
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 8
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 8
- 239000006260 foam Substances 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- VYCKDIRCVDCQAE-UHFFFAOYSA-N isoquinolin-3-amine Chemical compound C1=CC=C2C=NC(N)=CC2=C1 VYCKDIRCVDCQAE-UHFFFAOYSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 235000005979 Citrus limon Nutrition 0.000 description 6
- 244000131522 Citrus pyriformis Species 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- QEAGQILEKLFCEK-UHFFFAOYSA-N isoquinoline-7-carbaldehyde Chemical compound C1=CN=CC2=CC(C=O)=CC=C21 QEAGQILEKLFCEK-UHFFFAOYSA-N 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- BWKAYBPLDRWMCJ-UHFFFAOYSA-N 1,1-diethoxy-n,n-dimethylmethanamine Chemical compound CCOC(N(C)C)OCC BWKAYBPLDRWMCJ-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- IQFYYKKMVGJFEH-OYDXRQHMSA-N 1-[(2r,4s,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H]([14CH2]O)[C@@H](O)C1 IQFYYKKMVGJFEH-OYDXRQHMSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- PCJDRCGDIIPPST-UHFFFAOYSA-N 1-ethylsulfonylpiperidin-4-amine Chemical compound CCS(=O)(=O)N1CCC(N)CC1 PCJDRCGDIIPPST-UHFFFAOYSA-N 0.000 description 3
- JIADEIQNXDFOGT-UHFFFAOYSA-N 2,6-difluoro-n-(5-phenyl-1h-pyrazol-4-yl)benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC=CC=2)NN=C1 JIADEIQNXDFOGT-UHFFFAOYSA-N 0.000 description 3
- FSIBMLJFLPWMTD-UHFFFAOYSA-N 2-bromo-1-(4-iodophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(I)C=C1 FSIBMLJFLPWMTD-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- POXSQGDWTKWLQK-UHFFFAOYSA-N CC(CCCCCCCCCCCOCCl)(C)C Chemical compound CC(CCCCCCCCCCCOCCl)(C)C POXSQGDWTKWLQK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001299 aldehydes Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000031709 bromination Effects 0.000 description 3
- 238000005893 bromination reaction Methods 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- IMDXZWRLUZPMDH-UHFFFAOYSA-N dichlorophenylphosphine Chemical compound ClP(Cl)C1=CC=CC=C1 IMDXZWRLUZPMDH-UHFFFAOYSA-N 0.000 description 3
- QUFUUBBLCOBJPH-UHFFFAOYSA-N isoquinoline-7-carboxylic acid Chemical compound C1=CN=CC2=CC(C(=O)O)=CC=C21 QUFUUBBLCOBJPH-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 239000012285 osmium tetroxide Substances 0.000 description 3
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 2
- KEZNMOUMHOZFRA-UHFFFAOYSA-N 1h-pyrazol-4-ylboronic acid Chemical compound OB(O)C=1C=NNC=1 KEZNMOUMHOZFRA-UHFFFAOYSA-N 0.000 description 2
- VGIHKYVYKZBJKO-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound N1=CC2=CC(C#N)=CC=C2C2=C1C=NN2 VGIHKYVYKZBJKO-UHFFFAOYSA-N 0.000 description 2
- VWCXXNDPHWOUFJ-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;1-(trifluoromethylsulfonyl)piperidin-4-amine Chemical compound OC(=O)C(F)(F)F.NC1CCN(S(=O)(=O)C(F)(F)F)CC1 VWCXXNDPHWOUFJ-UHFFFAOYSA-N 0.000 description 2
- XTFDVTPMTAMGJT-UHFFFAOYSA-N 2,6-difluoro-n-[5-(4-fluorophenyl)-1h-pyrazol-4-yl]benzamide Chemical compound C1=CC(F)=CC=C1C1=C(NC(=O)C=2C(=CC=CC=2F)F)C=NN1 XTFDVTPMTAMGJT-UHFFFAOYSA-N 0.000 description 2
- ZYNOJKZMWJTNPF-UHFFFAOYSA-N 2,6-difluoro-n-[5-(4-iodophenyl)-1h-pyrazol-4-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=C(C=2C=CC(I)=CC=2)NN=C1 ZYNOJKZMWJTNPF-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- SWPQABRRODNXGL-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound C12=CC(C(=O)O)=CC=C2C2=NNC=C2N=C1C1=C(F)C=CC=C1F SWPQABRRODNXGL-UHFFFAOYSA-N 0.000 description 2
- GUQZRLYVVFIRHR-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F GUQZRLYVVFIRHR-UHFFFAOYSA-N 0.000 description 2
- JJLAATZLOUWPOB-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-iodo-1h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC(I)=CC=C11)=NC2=C1NN=C2 JJLAATZLOUWPOB-UHFFFAOYSA-N 0.000 description 2
- CTNSZZYEBNHWAK-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-n-(1-methylsulfonylpiperidin-4-yl)-7-(2h-triazol-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C3=NNN=C3)=C1N=C2C1=C(F)C=CC=C1F CTNSZZYEBNHWAK-UHFFFAOYSA-N 0.000 description 2
- QHKIYTIYSBOAME-UHFFFAOYSA-N 5-(4-iodophenyl)-1h-pyrazol-4-amine Chemical compound NC1=CNN=C1C1=CC=C(I)C=C1 QHKIYTIYSBOAME-UHFFFAOYSA-N 0.000 description 2
- QGFYFOHMBDMGBZ-UHFFFAOYSA-N 5-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol Chemical compound C1=C(O)C(CN(CC)CC)=CC=C1NC1=CC=NC2=CC(Cl)=CC=C12 QGFYFOHMBDMGBZ-UHFFFAOYSA-N 0.000 description 2
- YLYPTGYHGCWJGN-UHFFFAOYSA-N 5-phenyl-1h-pyrazol-4-amine Chemical compound C1=NNC(C=2C=CC=CC=2)=C1N YLYPTGYHGCWJGN-UHFFFAOYSA-N 0.000 description 2
- APKFPKLTEJAOJI-UHFFFAOYSA-N 6-butyldec-5-en-5-ylstannane Chemical compound CCCCC([SnH3])=C(CCCC)CCCC APKFPKLTEJAOJI-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 240000001414 Eucalyptus viminalis Species 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- HEUWEXGAILEABO-UHFFFAOYSA-N N-[[5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinolin-7-yl]methylidene]hydroxylamine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=NO)C=C22)=C1N=C2C1=C(F)C=CC=C1F HEUWEXGAILEABO-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- FCYRSDMGOLYDHL-UHFFFAOYSA-N chloromethoxyethane Chemical compound CCOCCl FCYRSDMGOLYDHL-UHFFFAOYSA-N 0.000 description 2
- USJRLGNYCQWLPF-UHFFFAOYSA-N chlorophosphane Chemical compound ClP USJRLGNYCQWLPF-UHFFFAOYSA-N 0.000 description 2
- NYERCBJKHBDQGO-UHFFFAOYSA-N diphenyl(9h-xanthen-1-yl)phosphane Chemical compound C=12CC3=CC=CC=C3OC2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 NYERCBJKHBDQGO-UHFFFAOYSA-N 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- GZZCYMXZJQCAJU-UHFFFAOYSA-N isoquinoline-1-sulfonamide Chemical compound C1=CC=C2C(S(=O)(=O)N)=NC=CC2=C1 GZZCYMXZJQCAJU-UHFFFAOYSA-N 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002923 oximes Chemical group 0.000 description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DXNSNJONYUFURO-UHFFFAOYSA-N tert-butyl n-[1-(trifluoromethylsulfonyl)piperidin-4-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCN(S(=O)(=O)C(F)(F)F)CC1 DXNSNJONYUFURO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZWNUPCHZMZEMMQ-UHFFFAOYSA-N (5-diphenylphosphanyl-1-methyl-9H-xanthen-4-yl)-diphenylphosphane Chemical compound C1(=CC=CC=C1)P(C1=CC=C(C=2CC3=CC=CC(=C3OC1=2)P(C1=CC=CC=C1)C1=CC=CC=C1)C)C1=CC=CC=C1 ZWNUPCHZMZEMMQ-UHFFFAOYSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- JZJWCDQGIPQBAO-UHFFFAOYSA-N 1-(4-iodophenyl)ethanone Chemical compound CC(=O)C1=CC=C(I)C=C1 JZJWCDQGIPQBAO-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- AOYXWYFGLFWATH-UHFFFAOYSA-N 1-cyclopropylsulfonylpiperidin-4-amine Chemical compound C1CC(N)CCN1S(=O)(=O)C1CC1 AOYXWYFGLFWATH-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WQYKPWBUFZKNPM-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound N1=CC2=CC(C=O)=CC=C2C2=C1C=NN2 WQYKPWBUFZKNPM-UHFFFAOYSA-N 0.000 description 1
- QRHUZEVERIHEPT-UHFFFAOYSA-N 2,6-difluorobenzoyl chloride Chemical compound FC1=CC=CC(F)=C1C(Cl)=O QRHUZEVERIHEPT-UHFFFAOYSA-N 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- ZDVZXGKOLIOHEW-UHFFFAOYSA-N 2-[1-(dimethylamino)-3-oxo-3-phenylprop-1-en-2-yl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(=CN(C)C)C(=O)C1=CC=CC=C1 ZDVZXGKOLIOHEW-UHFFFAOYSA-N 0.000 description 1
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 1
- FKLXVATYNSURCQ-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC=CC=C11)=NC2=C1NN=C2Br FKLXVATYNSURCQ-UHFFFAOYSA-N 0.000 description 1
- KBNWHGXGDFWFEW-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound FC1=CC=CC(F)=C1C(C1=CC(C=O)=CC=C11)=NC2=C1NN=C2Br KBNWHGXGDFWFEW-UHFFFAOYSA-N 0.000 description 1
- QWZQEEOABSXSBX-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2Br QWZQEEOABSXSBX-UHFFFAOYSA-N 0.000 description 1
- AYENXVFCTFUUJH-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-2h-pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound C12=CC(C(=O)O)=CC=C2C2=NNC(Br)=C2N=C1C1=C(F)C=CC=C1F AYENXVFCTFUUJH-UHFFFAOYSA-N 0.000 description 1
- OVSVWCBZHSUWOK-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-7-fluoro-2h-pyrazolo[4,3-c]isoquinoline Chemical compound C12=CC(F)=CC=C2C=2NN=C(Br)C=2N=C1C1=C(F)C=CC=C1F OVSVWCBZHSUWOK-UHFFFAOYSA-N 0.000 description 1
- OSMFQEYOPOGRAA-UHFFFAOYSA-N 3-bromo-5-(2,6-difluorophenyl)-7-iodo-2h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC(I)=CC=C11)=NC2=C1NN=C2Br OSMFQEYOPOGRAA-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KEVXLLCQBCBCJN-UHFFFAOYSA-N 4-[[7-cyano-5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinolin-3-yl]amino]piperidine-1-sulfonamide Chemical compound C1CN(S(=O)(=O)N)CCC1NC1=NNC(C2=CC=C(C=C22)C#N)=C1N=C2C1=C(F)C=CC=C1F KEVXLLCQBCBCJN-UHFFFAOYSA-N 0.000 description 1
- LFWVHNUWSZWUMH-UHFFFAOYSA-N 4-aminopiperidine-1-sulfonamide Chemical compound NC1CCN(S(N)(=O)=O)CC1 LFWVHNUWSZWUMH-UHFFFAOYSA-N 0.000 description 1
- GZFMOLQHCGDVDV-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline Chemical compound FC1=CC=CC(F)=C1C(C1=CC=CC=C11)=NC2=C1NN=C2 GZFMOLQHCGDVDV-UHFFFAOYSA-N 0.000 description 1
- RXDWSFDULBSFOF-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-1h-pyrazolo[4,3-c]isoquinoline-7-carbonitrile Chemical compound FC1=CC=CC(F)=C1C(C1=CC(=CC=C11)C#N)=NC2=C1NN=C2 RXDWSFDULBSFOF-UHFFFAOYSA-N 0.000 description 1
- KGRMVLZLUGWXOJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carbaldehyde Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=O)C=C22)=C1N=C2C1=C(F)C=CC=C1F KGRMVLZLUGWXOJ-UHFFFAOYSA-N 0.000 description 1
- NTUDVKOTCJWOGK-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C22)C(N)=O)=C1N=C2C1=C(F)C=CC=C1F NTUDVKOTCJWOGK-UHFFFAOYSA-N 0.000 description 1
- JEQFXIVSJGPTBW-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-ethenyl-n-(1-methylsulfonylpiperidin-4-yl)-1h-pyrazolo[4,3-c]isoquinolin-3-amine Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(C=C)C=C22)=C1N=C2C1=C(F)C=CC=C1F JEQFXIVSJGPTBW-UHFFFAOYSA-N 0.000 description 1
- YEWINKXAUYADIJ-UHFFFAOYSA-N 5-(2,6-difluorophenyl)-7-fluoro-1h-pyrazolo[4,3-c]isoquinoline Chemical compound C12=CC(F)=CC=C2C=2NN=CC=2N=C1C1=C(F)C=CC=C1F YEWINKXAUYADIJ-UHFFFAOYSA-N 0.000 description 1
- QUVOLGJMWPXAAL-UHFFFAOYSA-N 5-(4-fluorophenyl)-1h-pyrazol-4-amine Chemical compound C1=NNC(C=2C=CC(F)=CC=2)=C1N QUVOLGJMWPXAAL-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- QYCOMYXXCYZHKD-UHFFFAOYSA-N 6H-pyrazolo[4,3-c]isoquinoline-7-carboxamide Chemical compound N=1N=CC2=NC=C3CC(=CC=C3C21)C(=O)N QYCOMYXXCYZHKD-UHFFFAOYSA-N 0.000 description 1
- ABPZRJWKMSTIOW-UHFFFAOYSA-N 6H-pyrazolo[4,3-c]isoquinoline-7-carboxylic acid Chemical compound N=1N=CC2=NC=C3CC(=CC=C3C2=1)C(=O)O ABPZRJWKMSTIOW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 238000006407 Bischler-Napieralski reaction Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- KDBVOVZEFHUSSP-UHFFFAOYSA-N CN1N=CC=2N=CC=3C=CC=CC3C21 Chemical compound CN1N=CC=2N=CC=3C=CC=CC3C21 KDBVOVZEFHUSSP-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- NPBJEFSQGMNZKO-UHFFFAOYSA-N FC=1C=CC=2C3=C(N=CC2C1)C=NN3 Chemical compound FC=1C=CC=2C3=C(N=CC2C1)C=NN3 NPBJEFSQGMNZKO-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- STJJDNLONRBDPP-UHFFFAOYSA-N N-[[5-(2,6-difluorophenyl)-3-[(1-ethylsulfonylpiperidin-4-yl)amino]-1H-pyrazolo[4,3-c]isoquinolin-7-yl]methylidene]hydroxylamine Chemical compound C1CN(S(=O)(=O)CC)CCC1NC1=NNC(C2=CC=C(C=NO)C=C22)=C1N=C2C1=C(F)C=CC=C1F STJJDNLONRBDPP-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- MFAVPCFFKXHTGS-UHFFFAOYSA-N [5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinolin-7-yl]methanol Chemical compound C1CN(S(=O)(=O)C)CCC1NC1=NNC(C2=CC=C(CO)C=C22)=C1N=C2C1=C(F)C=CC=C1F MFAVPCFFKXHTGS-UHFFFAOYSA-N 0.000 description 1
- JCFWQBLQYTZMOF-UHFFFAOYSA-N [Cl-].C[NH2+]C.S Chemical compound [Cl-].C[NH2+]C.S JCFWQBLQYTZMOF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001804 chlorine Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- GOMCKELMLXHYHH-UHFFFAOYSA-L dipotassium;phthalate Chemical compound [K+].[K+].[O-]C(=O)C1=CC=CC=C1C([O-])=O GOMCKELMLXHYHH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- MQUPWTBHHPUUMC-UHFFFAOYSA-N isoindole Chemical compound C1=CC=C[C]2C=NC=C21 MQUPWTBHHPUUMC-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- BPPAQDYMIMQAEF-UHFFFAOYSA-N methyl 5-(2,6-difluorophenyl)-3-[(1-methylsulfonylpiperidin-4-yl)amino]-1h-pyrazolo[4,3-c]isoquinoline-7-carboxylate Chemical compound C1=2N=C(C=3C(=CC=CC=3F)F)C3=CC(C(=O)OC)=CC=C3C=2NN=C1NC1CCN(S(C)(=O)=O)CC1 BPPAQDYMIMQAEF-UHFFFAOYSA-N 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- IBSCADYIYSQTJC-UHFFFAOYSA-N methyl isoquinoline-7-carboxylate Chemical compound C1=CN=CC2=CC(C(=O)OC)=CC=C21 IBSCADYIYSQTJC-UHFFFAOYSA-N 0.000 description 1
- FCCPIHARAHEKBC-UHFFFAOYSA-N n-methylmethanamine;sulfuryl dichloride Chemical compound CNC.ClS(Cl)(=O)=O FCCPIHARAHEKBC-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229940127084 other anti-cancer agent Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- FLKRMXAWABTWSH-UHFFFAOYSA-N piperidine-1-sulfonamide Chemical compound NS(=O)(=O)N1CCCCC1 FLKRMXAWABTWSH-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- MMCIXNVRVDTQSG-UHFFFAOYSA-N quinoline-7-carboxamide Chemical compound C1=CC=NC2=CC(C(=O)N)=CC=C21 MMCIXNVRVDTQSG-UHFFFAOYSA-N 0.000 description 1
- NHWBVRAPBLSUQQ-UHFFFAOYSA-H ruthenium hexafluoride Chemical compound F[Ru](F)(F)(F)(F)F NHWBVRAPBLSUQQ-UHFFFAOYSA-H 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- LZRDHSFPLUWYAX-UHFFFAOYSA-N tert-butyl 4-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(N)CC1 LZRDHSFPLUWYAX-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901995A FR2944792B1 (fr) | 2009-04-24 | 2009-04-24 | Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201041887A TW201041887A (en) | 2010-12-01 |
| TWI468405B true TWI468405B (zh) | 2015-01-11 |
Family
ID=41259738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW99112914A TWI468405B (zh) | 2009-04-24 | 2010-04-23 | １Ｈ－吡唑并〔４，３－ｃ〕異喹啉衍生物、其製備及其於醫療上之應用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8461175B2 (enExample) |
| EP (1) | EP2421864B1 (enExample) |
| JP (1) | JP5722880B2 (enExample) |
| KR (1) | KR101675609B1 (enExample) |
| CN (1) | CN102459260B (enExample) |
| AR (1) | AR076393A1 (enExample) |
| AU (1) | AU2010240742B2 (enExample) |
| BR (1) | BRPI1013724A2 (enExample) |
| CA (1) | CA2791947A1 (enExample) |
| CY (1) | CY1115678T1 (enExample) |
| DK (1) | DK2421864T3 (enExample) |
| ES (1) | ES2515240T3 (enExample) |
| FR (1) | FR2944792B1 (enExample) |
| HR (1) | HRP20141058T1 (enExample) |
| IL (1) | IL215733A (enExample) |
| MX (1) | MX2011011246A (enExample) |
| MY (1) | MY156362A (enExample) |
| PL (1) | PL2421864T3 (enExample) |
| PT (1) | PT2421864E (enExample) |
| RU (1) | RU2530775C2 (enExample) |
| SG (1) | SG175338A1 (enExample) |
| SI (1) | SI2421864T1 (enExample) |
| TW (1) | TWI468405B (enExample) |
| UY (1) | UY32575A (enExample) |
| WO (1) | WO2010122272A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109020972B (zh) * | 2018-10-08 | 2021-03-09 | 广东石油化工学院 | 一种三唑并[1，5-a]喹啉衍生物的制备方法 |
| WO2023039510A1 (en) * | 2021-09-10 | 2023-03-16 | The Trustees Of Columbia University In The City Of New York | Gpx4 inhibitors and uses thereof |
| CN116535356A (zh) * | 2023-03-06 | 2023-08-04 | 中国药科大学 | 3-氨基-5-苯基-吡唑类衍生物微管蛋白抑制剂及其制备和医药用途 |
| EP4506003A1 (en) | 2023-08-07 | 2025-02-12 | S.Yu Yunusov Institute of Chemistry of Plant Substances of the Academy of Sciences of the Republic of Uzbekistan | Halogen derivatives of (4´,5´- methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline for use in the treatment of leukemia |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2185255A (en) * | 1986-01-14 | 1987-07-15 | Roussel Lab Ltd | Pyrazolo-isoquinoline compounds |
| US20040097541A1 (en) * | 2002-07-03 | 2004-05-20 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinoline derivatives for inhibiting NFkappaB-inducing kinase |
| US20050009859A1 (en) * | 2003-07-03 | 2005-01-13 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| WO2007060198A1 (en) * | 2005-11-25 | 2007-05-31 | Palau Pharma, S. A. | Pyrazoloisoquinoline derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2531291A1 (en) * | 2003-07-03 | 2005-02-10 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivatives as kinase inhibitors |
| AU2004259012C1 (en) * | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
-
2009
- 2009-04-24 FR FR0901995A patent/FR2944792B1/fr not_active Expired - Fee Related
-
2010
- 2010-04-22 CA CA2791947A patent/CA2791947A1/fr not_active Abandoned
- 2010-04-22 SI SI201030757T patent/SI2421864T1/sl unknown
- 2010-04-22 MY MYPI2011005108A patent/MY156362A/en unknown
- 2010-04-22 ES ES10723723.2T patent/ES2515240T3/es active Active
- 2010-04-22 HR HRP20141058AT patent/HRP20141058T1/hr unknown
- 2010-04-22 US US13/265,981 patent/US8461175B2/en not_active Expired - Fee Related
- 2010-04-22 BR BRPI1013724A patent/BRPI1013724A2/pt not_active IP Right Cessation
- 2010-04-22 SG SG2011077963A patent/SG175338A1/en unknown
- 2010-04-22 EP EP10723723.2A patent/EP2421864B1/fr active Active
- 2010-04-22 CN CN201080028355.1A patent/CN102459260B/zh not_active Expired - Fee Related
- 2010-04-22 MX MX2011011246A patent/MX2011011246A/es active IP Right Grant
- 2010-04-22 PT PT107237232T patent/PT2421864E/pt unknown
- 2010-04-22 PL PL10723723T patent/PL2421864T3/pl unknown
- 2010-04-22 KR KR1020117027900A patent/KR101675609B1/ko not_active Expired - Fee Related
- 2010-04-22 AU AU2010240742A patent/AU2010240742B2/en not_active Ceased
- 2010-04-22 JP JP2012506551A patent/JP5722880B2/ja not_active Expired - Fee Related
- 2010-04-22 DK DK10723723.2T patent/DK2421864T3/da active
- 2010-04-22 RU RU2011147658/04A patent/RU2530775C2/ru not_active IP Right Cessation
- 2010-04-22 WO PCT/FR2010/050773 patent/WO2010122272A1/fr not_active Ceased
- 2010-04-23 UY UY0001032575A patent/UY32575A/es not_active Application Discontinuation
- 2010-04-23 TW TW99112914A patent/TWI468405B/zh not_active IP Right Cessation
- 2010-04-23 AR ARP100101357A patent/AR076393A1/es unknown
-
2011
- 2011-10-11 IL IL215733A patent/IL215733A/en not_active IP Right Cessation
-
2014
- 2014-10-30 CY CY20141100897T patent/CY1115678T1/el unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2185255A (en) * | 1986-01-14 | 1987-07-15 | Roussel Lab Ltd | Pyrazolo-isoquinoline compounds |
| US20040097541A1 (en) * | 2002-07-03 | 2004-05-20 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinoline derivatives for inhibiting NFkappaB-inducing kinase |
| US20050009859A1 (en) * | 2003-07-03 | 2005-01-13 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| WO2007060198A1 (en) * | 2005-11-25 | 2007-05-31 | Palau Pharma, S. A. | Pyrazoloisoquinoline derivatives |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2314690T3 (es) | Derivados de triazolopiridinilsulfanilo como inhibidores de la map quinasa p38. | |
| CN108699077B (zh) | 作为rsv抑制剂的杂环化合物 | |
| CA2822003C (en) | Imidazopyridines as respiratory syncytial virus antiviral agents | |
| CN113906032A (zh) | 用于制备对映异构体富集的jak抑制剂的方法 | |
| CN115996727B (zh) | 新型Rho相关蛋白激酶抑制剂的制备方法和此制备方法中的中间体 | |
| TWI294421B (en) | Methods of preparing indazole compounds | |
| US20070203196A1 (en) | Methods of preparing indazole compounds | |
| TW201321378A (zh) | 用於製造氮雜吲哚之方法及中間物 | |
| CN104428300A (zh) | 酶的抑制 | |
| TWI468405B (zh) | １Ｈ－吡唑并〔４，３－ｃ〕異喹啉衍生物、其製備及其於醫療上之應用 | |
| NZ587141A (en) | Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments | |
| AU2005210459A1 (en) | Kinase inhibitors | |
| DE60319254T2 (de) | Pyrazolamide zur behandlung von hiv-infektionen | |
| TWI295926B (en) | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors | |
| JP2009512666A (ja) | ６−ヘテロアリールピリドインドロン誘導体、その調製及び治療的使用 | |
| HK1170736B (en) | 1h-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof | |
| HK1167387B (en) | 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof | |
| HK1124044A (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |